NEW YORK (GenomeWeb News) — Shares in Helicos were down 5.6 percent, or $.50, at $8.50 in afternoon trading today, the stock's first day of trading on the Nasdaq exchange.
 
The company lowered its IPO price twice in as many days this week, dropping it between 30 and 40 percent from the original $13 to $15 range down to the $9 per share that it began trading at this morning.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.